coyotebio产品代理

Coyote Bioscience Co., Ltd. (“Coyote”) is a Chinese innovative high-tech company that has been engaged in molecular 

iagnostics   for 10 years, and it especially excels at the fast nucleic acid detection   technology for pathogenic microorganisms. Coyote’s core   technologies with independent intellectual property rights enable the company   to participate in joint development in such interdisciplinary fields as   related to instruments, reagents, system platforms, artificial intelligence   and big data.

Coyote was   founded in 2009, with its headquarters and R&D center in Beijing and an   8,000 square meter GMP production base in Yixing, Jiangsu Province. As a   national high-tech enterprise and an experts’ base, the company has been awarded such honors as “China’s Top 50 Most   Valuable Enterprises for Investment”, “China’s Most Promising Enterprise”, and “Advanced Collective” for combating the COVID-19 pandemic by the Ministry of Industry   and Information Technology in 2020.

Coyote has applied for 83 domestic and international patents, mainly including 22 international PCT patents, 13 domestically authorized patents, 2 US patents and 1 Australian patent. It has participated in the Torch Program of the Ministry of Science and Technology and national major programs for infectious diseases. The corporate vision, “molecular diagnostics for everyone”, which has served as the source of Coyote’s technological innovation in the past 10 years, is also its historical mission in the context of the normalized